“What’s interesting about them is that they were kind of late getting their license as a producer. They ended up becoming more of a white label wholesaler into companies like [Canopy Growth], and that has been a fantastic place to be because there’s a shortage of flower,” said Hodgins, president and chief investment officer at Curvature, to BNN Bloomberg on Monday.
Not enough stock on the shelves has been an ongoing issue for private as well as provincial cannabis retailers, as the industry makes its way through the first few months of a legal rec market. In March, Health Canada reported sales of dried cannabis for the month of January which were down 3.7 per cent from December and the lowest sales numbers since the market opened in October.
Supreme, which is expected to release its quarterly financials later this month, posted its second quarter fiscal 2019 results in mid-February, coming in with a loss of $1.55 million on revenue of $7.72 million, a 359-per-cent increase year-over-year.
Hodgins says Supreme’s upcoming Q3 should be favourable.
“Supreme is getting good pricing on their products and they’re selling everything that they can produce without having too much of the infrastructure costs that the other LPs would have. So in terms of the financials, we expect them to be quite strong,” he says.
Last week, Supreme Cannabis announced the launch of Cambium Plant Sciences, a subsidiary aimed at genetics research. The company plans to put $14 million into the venture, including the construction of a 34,000 square foot research facility in Goderich, Ontario.
Year-to-date, FIRE is up 53 per cent.
It's just getting started. That's the takeaway from new coverage of HEALWELL AI (HEALWELL AI Stock Quote, Chart, News, Analysts,… [Read More]
Following the company's fourth quarter results, Scotia analyst Konark Gupta has raised his price target on MDA (MDA Stock Quote,… [Read More]
Following the company's fourth quarter results, National Bank Financial analyst Richard Tse has raised his price target on Constellation Software… [Read More]
Following the company's fourth quarter results, Ventum Capital Markets analyst Andrew Semple has downgraded and cut his price target on… [Read More]
Following the company's third quarter results, Ventum Capital Markets analyst Amr Ezzat has maintained his "Buy" rating and "Top Pick"… [Read More]
A dice roll. That's what stock pundit Jim Cramer calls BlackBerry (BlackBerry Stock Quote, Chart, News, Analysts, Financials NYSE:BB) stock… [Read More]